Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Int J Mol Sci ; 22(5)2021 Feb 24.
Article in English | MEDLINE | ID: mdl-33668324

ABSTRACT

FOXC1, a transcription factor involved in cell differentiation and embryogenesis, is demonstrated to be a negative regulator of Nanog in this study. FOXC1 is up-regulated in retinoic acid-induced differentiation of F9 Embryonal Carcinoma (EC) cells; furthermore, FOXC1 specifically inhibits the core pluripotency factor Nanog by binding to the proximal promoter. Overexpression of FOXC1 in F9 or knockdown in 3T3 results in the down-regulation or up-regulation of Nanog mRNA and proteins, respectively. In order to explain the mechanism by which FOXC1 inhibits Nanog expression, we identified the co-repressor HDAC2 from the FOXC1 interactome. FOXC1 recruits HDAC2 to Nanog promoter to decrease H3K27ac enrichment, resulting in transcription inhibition of Nanog. To the best of our knowledge, this is the first report that FOXC1 is involved in the epigenetic regulation of gene expression.


Subject(s)
Embryonal Carcinoma Stem Cells/metabolism , Forkhead Transcription Factors/metabolism , Gene Expression Regulation, Neoplastic/drug effects , Histone Deacetylase 2/metabolism , Nanog Homeobox Protein/genetics , Promoter Regions, Genetic , Tretinoin/pharmacology , Animals , Antineoplastic Agents/pharmacology , Embryonal Carcinoma Stem Cells/drug effects , Embryonal Carcinoma Stem Cells/pathology , Epigenesis, Genetic , Forkhead Transcription Factors/genetics , HEK293 Cells , Histone Deacetylase 2/genetics , Humans , Mice , NIH 3T3 Cells , Nanog Homeobox Protein/metabolism
3.
Mol Cell Biol ; 40(8)2020 03 30.
Article in English | MEDLINE | ID: mdl-31988106

ABSTRACT

Intracellular pathogen resistance 1 (Ipr1) has been found to be a mediator to integrate cyclic GMP-AMP synthase (cGAS)-interferon regulatory factor 3 (IRF3), activated by intracellular pathogens, with the p53 pathway. Previous studies have shown the process of Ipr1 induction by various immune reactions, including intracellular bacterial and viral infections. The present study demonstrated that Ipr1 is regulated by the cGAS-IRF3 pathway during pathogenic infection. IRF3 was found to regulate Ipr1 expression by directly binding the interferon-stimulated response element motif of the Ipr1 promoter. Knockdown of Ipr1 decreased the expression of immunity-related GTPase family M member 1 (Irgm1), which plays critical roles in autophagy initiation. Irgm1 promoter characterization revealed a p53 motif in front of the transcription start site. P53 was found to participate in regulation of Irgm1 expression and IPR1-related effects on P53 stability by affecting interactions between ribosomal protein L11 (RPL11) and transformed mouse 3T3 cell double minute 2 (MDM2). Our results indicate that Ipr1 integrates cGAS-IRF3 with p53-modulated Irgm1 expression.


Subject(s)
GTP-Binding Proteins/metabolism , Interferon Regulatory Factor-3/metabolism , Nucleotides, Cyclic/metabolism , Trans-Activators/metabolism , Tumor Suppressor Protein p53/metabolism , Animals , Cytoplasm/metabolism , GTP-Binding Proteins/genetics , HEK293 Cells , Humans , Interferon Regulatory Factor-3/genetics , Macrophages/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , NIH 3T3 Cells , Nucleotides, Cyclic/genetics , Nucleotidyltransferases/genetics , Nucleotidyltransferases/metabolism , Promoter Regions, Genetic , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins c-mdm2/genetics , Proto-Oncogene Proteins c-mdm2/metabolism , RAW 264.7 Cells , Ribosomal Proteins/metabolism , Signal Transduction , Trans-Activators/genetics , Tumor Suppressor Protein p53/genetics
4.
Autophagy ; 16(8): 1453-1467, 2020 08.
Article in English | MEDLINE | ID: mdl-31711362

ABSTRACT

BAG2 (BCL2 associated athanogene 2) is associated with cell fate determination in response to various pathological conditions. However, the effects of BAG2 on M. tuberculosis-induced endoplasmic reticulum (ER) stress remain elusive. Herein, we report that M. tuberculosis infection of macrophages triggered ER stress and downregulated BAG2 expression. Overexpression of BAG2 enhanced autophagic flux and activated macroautophagy/autophagy targeted to the ER (reticulophagy). In addition, through increasingly localizing SQSTM1 to the ER in BAG2-overexpressing macrophages, we found that the autophagy receptor protein SQSTM1/p62 (sequestosome 1) is associated with the BAG2-induced reticulophagy. Our data also confirmed that BAG2 could render cells resistant to M. tuberculosis-induced cellular damage, and the anti-apoptotic effects of BAG2 in M. tuberculosis-treated macrophages were partially abolished by the autophagic flux inhibitor bafilomycin A1. Furthermore, the dissociation of BECN1 and BCL2 mediated by activation of mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) was responsible for BAG2-activated autophagy. In addition, XBP1 downstream of the ERN1/IRE1 signaling pathway was bound to the Bag2 promoter region and transcriptionally inhibited BAG2 expression. Collectively, these results indicated that BAG2 has anti-apoptotic effects on M. tuberculosis-induced ER stress, which is dependent on the promotion of autophagic flux and the induction of selective autophagy. We revealed a potential host defense mechanism that links BAG2 to ER stress and autophagy during M. tuberculosis infection. ABBREVIATIONS: ATF6: activating transcription factor 6; BECN1: beclin 1; Baf A1: bafilomycin A1; CASP3: caspase 3; DDIT3/CHOP/GADD153: DNA damage inducible transcript 3; DAPI: 4',6-diamidino-2-phenylindole; EIF2AK3/PERK: eukaryotic translation initiation factor 2 alpha kinase 3; ER: endoplasmic reticulum; ERN1/IRE1: endoplasmic reticulum to nucleus signaling 1; HSPA5/GRP78/BiP: heat shock protein 5; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; MAPK/ERK: mitogen-activated protein kinase; SQSTM1/p62: sequestosome 1; UPR: unfolded protein response; XBP1: x-box binding protein 1.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Apoptosis , Autophagy , Endoplasmic Reticulum Stress , Macrophages/microbiology , Molecular Chaperones/metabolism , Mycobacterium tuberculosis/physiology , Tuberculosis/microbiology , Tuberculosis/pathology , Animals , Beclin-1/metabolism , Down-Regulation , Endoplasmic Reticulum Chaperone BiP , Female , Mice , Mice, Inbred C57BL , Proto-Oncogene Proteins c-bcl-2/metabolism , RAW 264.7 Cells , X-Box Binding Protein 1/metabolism
5.
PLoS One ; 14(11): e0224822, 2019.
Article in English | MEDLINE | ID: mdl-31770378

ABSTRACT

BACKGROUND: The Saiga antelope (Saiga tatarica) is a critically endangered species, and there has been limited success in restoring the population by captive breeding. This study assessed the biochemical and physiological parameters of newborn Saiga antelope to provide reference information that can be used to evaluate their health. Comparisons have been made with parameters for horses and closely related members of the Bovidae family but there are no reference values for the newborn Saiga antelope. METHODS: Biochemical and physiological parameters were measured in 61 animals. An automatic analyzer (Hitachi Ltd. 7180 Serial, Tokyo, Japan) was used to analyze the biochemical parameters, while the Coulter counter (Model ZK) was used to analyze the physiological parameters. RESULTS: The results showed that the biochemical and physiological parameters differ considerably in range. The evaluation of parameters stratified by sex showed differences. Triglyceride and LDL cholesterol concentrations among male animals were significantly higher than those in female animals, while the creatine kinase concentrations were significantly higher in females than in males. Comparing this study's results with published data for horses showed many similarities and some differences. Cholesterol, magnesium and glucose levels were similar between Saiga antelope and horses, while albumin and hematocrit levels in Saiga antelope differed from the reference values in horses. CONCLUSION: The study has shown that horses and even closely related members of the Bovidae family are not suitable references when evaluating the biochemical and physiological properties of newborn Saiga antelope. These animals have unique stressors and warrant further study to inform efforts pertaining to their care and the future sustainability of the species.


Subject(s)
Antelopes/physiology , Animals , Animals, Newborn , China , Female , Horses/physiology , Male
6.
J Immunol ; 200(10): 3506-3518, 2018 05 15.
Article in English | MEDLINE | ID: mdl-29661829

ABSTRACT

Mycobacterium tuberculosis poses a significant global health threat. MicroRNAs play an important role in regulating host anti-mycobacterial defense; however, their role in apoptosis-mediated mycobacterial elimination and inflammatory response remains unclear. In this study, we explored the role of microRNA-27b (miR-27b) in murine macrophage responses to M. tuberculosis infection. We uncovered that the TLR-2/MyD88/NF-κB signaling pathway induced the expression of miR-27b and miR-27b suppressed the production of proinflammatory factors and the activity of NF-κB, thereby avoiding an excessive inflammation during M. tuberculosis infection. Luciferase reporter assay and Western blotting showed that miR-27b directly targeted Bcl-2-associated athanogene 2 (Bag2) in macrophages. Overexpression of Bag2 reversed miR-27b-mediated inhibition of the production of proinflammatory factors. In addition, miR-27b increased p53-dependent cell apoptosis and the production of reactive oxygen species and decreased the bacterial burden. We also showed that Bag2 interacts with p53 and negatively regulates its activity, thereby controlling cell apoptosis and facilitating bacterial survival. In summary, we revealed a novel role of the miR-27b/Bag2 axis in the regulation of inflammatory response and apoptosis and provide a potential molecular host defense mechanism against mycobacteria.


Subject(s)
Apoptosis/genetics , Inflammation/genetics , MicroRNAs/genetics , Tuberculosis/genetics , Adaptor Proteins, Signal Transducing/genetics , Animals , Cell Line , Female , HEK293 Cells , Humans , Macrophages/metabolism , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mycobacterium tuberculosis/pathogenicity , NF-kappa B/genetics , Proto-Oncogene Proteins c-bcl-2/genetics , RAW 264.7 Cells , Reactive Oxygen Species/metabolism , Signal Transduction/genetics , Tuberculosis/metabolism
7.
Oncotarget ; 8(38): 64050-64065, 2017 Sep 08.
Article in English | MEDLINE | ID: mdl-28969051

ABSTRACT

Tuberculosis remains a leading health problem worldwide and still accounts for about 1.3 million deaths annually. Expression of the mouse Sp110 nuclear body protein (Sp110) upregulates the apoptotic pathway, which plays an essential role in enhancing host immunity to Mycobacterium tuberculosis (Mtb). However, the mechanism of this upregulation is unclear. Here, we have identified 253 proteins in mouse macrophages that interact with Sp110, of which 251 proteins were previously uncharacterized. The results showed that Sp110 interacts with heat shock protein 5 (Hspa5) to activate endoplasmic reticulum (ER) stress-induced apoptosis, and that this is essential for Sp110 enhanced macrophage resistance to Mtb. Inhibition of the ER stress pathway abolishing the Sp110-enhanced macrophage apoptosis and resulted in increased intracellular survival of Mtb in macrophages overexpressing Sp110 Further studies revealed that Sp110 also interacts with the RNA binding protein, Ncl to promote its degradation. Consequently, the expression of Bcl2, usually stabilized by Ncl, was downregulated in Sp110 overexpressing macrophages. Moreover, overexpression of Sp110 promotes degradation of ribosomal protein Rps3a, resulting in upregulation of the activity of the pro-apoptotic poly (ADP-ribose) polymerase (PARP). In addition, macrophages from transgenic cattle with increased Sp110 expression confirmed that activation of the ER stress response is the main pathway through which Sp110-enhanced macrophages impart resistance to Mtb. This work has revealed the mechanism of Sp110 enhanced macrophage apoptosis in response to Mtb infection, and provides new insights into the study of host-pathogen interactions.

8.
J Cell Sci ; 130(10): 1740-1751, 2017 05 15.
Article in English | MEDLINE | ID: mdl-28348106

ABSTRACT

In murine macrophages infected with Mycobacterium tuberculosis (Mtb), the level of phosphorylated STAT1 (P-STAT1), which drives the expression of many pro-apoptosis genes, increases quickly but then declines over a period of hours. By contrast, infection induces a continued increase in the level of unphosphorylated STAT1 that persists for several days. Here, we found that the level of unphosphorylated STAT1 correlated with the intracellular bacterial burden during the later stages of infection. To investigate the significance of a high level of unphosphorylated STAT1, we increased its concentration exogenously, and found that the apoptosis rate induced by Mtb was sufficiently decreased. Further experiments confirmed that unphosphorylated STAT1 affects the expression of several immune-associated genes and lessens the sensitivity of macrophages to CD95 (FAS)-mediated apoptosis during Mtb infection. Furthermore, we characterized 149 proteins that interacted with unphosphorylated STAT1 and the interactome network. The cooperation between unphosphorylated STAT1 and STAT3 results in downregulation of CD95 expression. Additionally, we verified that unphosphorylated STAT1 and IFIT1 competed for binding to eEF1A. Taken together, our data show that the role of unphosphorylated STAT1 differs from that of P-STAT1, and represses apoptosis in macrophages to promote immune evasion during Mtb infection.


Subject(s)
Apoptosis , Macrophages/metabolism , Macrophages/microbiology , Mycobacterium tuberculosis/physiology , STAT1 Transcription Factor/metabolism , Adaptor Proteins, Signal Transducing , Animals , Binding, Competitive , Carrier Proteins/metabolism , Fas Ligand Protein/metabolism , Macrophages/pathology , Mice , Mice, Inbred C57BL , Models, Biological , Peptide Elongation Factor 1/metabolism , Phosphorylation , Protein Interaction Maps , RAW 264.7 Cells , RNA-Binding Proteins , STAT3 Transcription Factor/metabolism , Transcription, Genetic , Tuberculosis/metabolism , Tuberculosis/microbiology , fas Receptor/genetics , fas Receptor/metabolism
9.
Sci Rep ; 6: 22041, 2016 Feb 25.
Article in English | MEDLINE | ID: mdl-26912204

ABSTRACT

Human tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a leading global health problem, causing 1.3 million deaths each year. The nuclear body protein, Sp110, has been linked to TB resistance and previous work showed that it enhances macrophage apoptosis upon Mtb infection. Here, we report on the role of Sp110 in transcriptional regulation of macrophage responses to Mtb through integrated transcriptome and mechanistic studies. Transcriptome analysis revealed that Sp110 regulates genes involved in immune responses, apoptosis, defence responses, and inflammatory responses. Detailed investigation revealed that, in addition to apoptosis-related genes, Sp110 regulates cytokines, chemokines and genes that regulate intracellular survival of Mtb. Moreover, Sp110 regulates miRNA expression in macrophages, with immune and apoptosis-related miRNAs such as miR-125a, miR-146a, miR-155, miR-21a and miR-99b under Sp110 regulation. Additionally, our results showed that Sp110 upregulates BCL2 modifying factor (Bmf) by inhibiting miR-125a, and forced expression of Bmf induces macrophage apoptosis. These findings not only reveal the transcriptional basis of Sp110-mediated macrophage resistance to Mtb, but also suggest potential regulatory roles for Sp110 related to inflammatory responses, miRNA profiles, and the intracellular growth of Mtb.


Subject(s)
Disease Resistance/genetics , Macrophages/microbiology , Macrophages/physiology , Minor Histocompatibility Antigens/genetics , Mycobacterium tuberculosis/immunology , Nuclear Proteins/genetics , Transcription, Genetic , Animals , Apoptosis/genetics , Apoptosis/immunology , Cell Line , Chemokines/metabolism , Cluster Analysis , Cytokines/metabolism , Gene Expression Profiling , Gene Expression Regulation , Host-Pathogen Interactions , Macrophage Activation/immunology , Mice , MicroRNAs/genetics , Microbial Viability/immunology , Tuberculosis/genetics , Tuberculosis/immunology , Tuberculosis/microbiology
10.
Immunol Res ; 64(1): 143-54, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26590945

ABSTRACT

Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis, which most commonly affects the lungs and causes over 1.3 million people die annually. Variation in host genes is known to influence susceptibility to tuberculosis. Expression of the intracellular pathogen resistance 1 (Ipr1) gene could enhance the host resistance to mycobacterium. Here, we analyzed the coding region sequence and promoter of Ipr1 gene of mouse strains C57BL/6 and BALB/c. We found that the coding sequences of Ipr1 gene both in C57BL/6 and in BALB/c mice encode the same protein, while the Ipr1 promoter of BALB/c exists a short deletion and showed a slight of decreased transcriptional activity when compared with C57BL/6. Moreover, the optimal and minimal Ipr1 promoter was identified by luciferase assays using truncated reporter constructs, and the region from -293 to +95 bp showed the highest transcriptional activity and responsible for IFN-γ stimulation. Furthermore, the results showed that IFN-γ activates JAK/STAT and NF-κB signaling pathways to induce Ipr1 expression, and the signal transducer and activator of transcription 1 (Stat1) are critical for IFN-γ-induced Ipr1 expression, because overexpression of Stat1 promotes Ipr1 transcription, but knockdown of Stat1 reduced Ipr1 expression. Collectively, for the first time, our study characterizes Ipr1 promoter and investigates the positive and negative regulation of Ipr1 expression, providing basic data for application of Ipr1 in animal breeding.


Subject(s)
Gene Expression Regulation , Macrophages/immunology , Mycobacterium tuberculosis/immunology , Promoter Regions, Genetic/genetics , STAT1 Transcription Factor/metabolism , Trans-Activators/genetics , Tuberculosis, Pulmonary/genetics , Animals , Cells, Cultured , Genetic Predisposition to Disease , Humans , Immunity, Innate/genetics , Interferon-gamma/metabolism , Macrophages/microbiology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Polymorphism, Genetic , STAT1 Transcription Factor/genetics , Transcriptional Activation/genetics
11.
Sci Rep ; 5: 8666, 2015 Mar 02.
Article in English | MEDLINE | ID: mdl-25727520

ABSTRACT

Wnt/ß-catenin signalling plays a prominent role in maintaining self-renewal and pluripotency of mouse embryonic stem cells (mESCs). microRNAs (miRNAs) have critical roles in maintaining pluripotency and directing reprogramming. To investigate the effect of GSK3 inhibitors on miRNA expression, we analysed the miRNA expression profile of J1 mESCs in the absence or presence of CHIR99021 (CHIR) or 6-bromoindirubin-3'-oxime (BIO) by small RNA deep-sequencing. The results demonstrate that CHIR and BIO decrease mature miRNAs of most miRNA species, 90.4% and 98.1% of the differentially expressed miRNAs in BIO and CHIR treated cells were downregulated respectively. CHIR and BIO treatment leads to a slight upregulation of the primary transcripts of the miR-302-367 cluster and miR-181 family of miRNAs, these miRNAs are activated by Wnt/ß-catenin signalling. However, the precursor and mature form of the miR-302-367 cluster and miR-181 family of miRNAs are downregulated by CHIR, suggesting CHIR inhibits maturation of primary miRNA. Western blot analysis shows that BIO and CHIR treatment leads to a reduction of the RNase III enzyme Drosha in the nucleus. These data suggest that BIO and CHIR inhibit miRNA maturation by disturbing nuclear localisation of Drosha. Results also show that BIO and CHIR induce miR-211 expression in J1 mESCs.


Subject(s)
Glycogen Synthase Kinase 3/antagonists & inhibitors , Indoles/pharmacology , MicroRNAs/metabolism , Mouse Embryonic Stem Cells/metabolism , Oximes/pharmacology , Pyridines/pharmacology , Pyrimidines/pharmacology , RNA Processing, Post-Transcriptional/drug effects , Animals , Cell Cycle/drug effects , Cell Cycle/genetics , Cell Line , Cell Self Renewal/drug effects , Cell Self Renewal/genetics , Cell Shape/drug effects , Colony-Forming Units Assay , Epigenesis, Genetic/drug effects , Glycogen Synthase Kinase 3/metabolism , High-Throughput Nucleotide Sequencing , Mice , MicroRNAs/genetics , Mouse Embryonic Stem Cells/cytology , Multigene Family , Protein Kinase Inhibitors/pharmacology , RNA Processing, Post-Transcriptional/genetics , Ribonuclease III/metabolism , Sequence Analysis, RNA , Transcription Factors/metabolism , Wnt Signaling Pathway/drug effects , Wnt Signaling Pathway/genetics , beta Catenin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...